Barriers and facilitators related to HCV treatment uptake among HIV coinfected populations in Canada: Patient and treatment provider perceptions [0.03%]
加拿大HIV感染者中影响HCV治疗的相关障碍及促进因素：患者和治疗提供者的观点
David Ortiz-Paredes,Afia Amoako,David Lessard et al.
David Ortiz-Paredes et al.
Background: Direct-acting antiviral (DAA) uptake is challenging across HIV-hepatitis C (HCV) coinfected populations. This study sought to identify barriers and facilitators related to DAA uptake in priority populations in...
A rare case of gastric varices and splenic artery aneurysm secondary to splenic arteriovenous fistula [0.03%]
罕见的胃静脉曲张和脾动脉瘤伴脾动静脉瘘病例报告
Felix Zhou,Christopher B Lightfoot,Geoff Williams et al.
Felix Zhou et al.
A 33-year-old male with no relevant medical history presented with a few months of fatigue and reduced exercise tolerance and was found to have iron-deficiency anemia. An esophagogastroduodenoscopy revealed a cluster of isolated gastric fun...
Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CanHepC), the Canadian Association of Hepatology Nurses (CAHN), and the Canadian NASH Network 2022 Abstracts [0.03%]
加拿大肝病研究协会(CASL)、加拿大丙型肝炎网络(CanHepC)、加拿大肝病护士协会(CAHN)和加拿大NASH网络2022年大会摘要集
Ukraine strong [0.03%]
乌克兰依然强大
Eric M Yoshida,Natasha Chandok
Eric M Yoshida
Elevated serum ferritin in non-alcoholic fatty liver disease is not predictive of fibrosis [0.03%]
非酒精性脂肪肝患者血清铁蛋白升高不预示肝纤维化
Roberto Trasolini,Ben Cox,Ciaran Galts et al.
Roberto Trasolini et al.
Background: Non-alcoholic fatty liver disease (NAFLD) is common with widely ranging severity. Non-invasive risk scores for risk stratification are recommended but misclassify a significant proportion of patients. In situa...
Checkpoint inhibition in hepatocellular carcinoma: Outsmarting the Squid Game [0.03%]
免疫检查点抑制剂在肝细胞癌治疗中的应用：“智胜鱿鱼游戏”
Natasha Chandok,Sanjeev Sirpal,Eric M Yoshida
Natasha Chandok
ECHO+: Improving access to hepatitis C care within Indigenous communities in Alberta, Canada [0.03%]
ECHO+:改善加拿大阿尔伯塔省原住民社区乙型肝炎护理的可及性
Kate Pr Dunn,Kienan P Williams,Cari E Egan et al.
Kate Pr Dunn et al.
Background: Indigenous populations experience higher rates of hepatitis C virus (HCV) infections in Canada. The Extension for Community Health Outcomes+ (ECHO+) telehealth model was implemented in Alberta to support HCV s...
Seroprevalence of hepatitis B in previously undiagnosed patients: A community screening study [0.03%]
既往未诊断慢性乙肝患者血清流行率：一项社区筛查研究
Daljeet Chahal,Joseph Gh Lee,Eric M Yoshida et al.
Daljeet Chahal et al.
Background: Forty percent of hepatitis B carriers have no knowledge of their diagnosis. A prior study in British Columbia suggested high rates of hepatitis B among immigrants. The authors undertook a large-scale screening...
Shannon J Brown,Linh T Cosgrove,Samuel S Lee
Shannon J Brown
Prescribing trends in direct-acting antivirals for the treatment of hepatitis C in Ontario, Canada [0.03%]
加拿大安大略省抗丙型肝炎直接作用抗病毒药物的处方趋势
Mina Tadrous,Kate Mason,Zoë Dodd et al.
Mina Tadrous et al.
Background: Direct-acting antivirals (DAA) offer an opportunity to cure hepatitis C. Reimbursement for DAAs has changed on two occasions since their inclusion on the Ontario public formulary. Whether these changes have ap...